Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

Abstract SARS-CoV-2 continues to be a public health burden, driven in-part by its continued antigenic diversification and resulting emergence of new variants. By increasing herd immunity, current vaccines have improved infection outcomes for many. However, prophylactic and treatment interventions th...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana Chang, Ahmed Mostafa, Madhubanti Basu, Sanghita Sarkar, Simran Panjwani, Yaelyn H. Ha, Yao Ma, Chengjin Ye, Qian Wang, Todd J. Green, James L. Kizziah, Nathaniel B. Erdmann, Paul A. Goepfert, Lihong Liu, David D. Ho, Luis Martinez-Sobrido, Mark R. Walter, James J. Kobie
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:npj Viruses
Online Access:https://doi.org/10.1038/s44298-024-00063-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s44298-024-00063-z

Similar Items